Deleted Tweets From Scott Gottlieb, R-D.C.

RT @FDAOncology: Check out this opportunity to work with us at #FDAOncology, @theNCI and @AACR on cancer research-related policy issues. Ap… QT @AACR: The deadline for the AACR Science Policy Fellowship application is midnight tonight. Don’t miss your chance to appl… https://t.co/KngsEe40K4)

FDA isn’t asking for applications to approve flavors in cigars. We’re issuing guidance to end enforcement discretion and then regulation to ban flavors in all cigars. There’s no place for flavors in cigars. This was made clear in our Nov 2018 announcement https://t.co/5FiuE4dyZd

RT @FDAOMH: FDA Office of Minority Health in collaboration with @SOPHEtweets is calling for abstracts for the Health Promotion… https://t.co/axFgWCGSxu

RT @FDAanimalhealth: Interested in helping FDA investigate the potential link between diet & � heart disease? Learn what you can do by v… https://t.co/SACVYQKyW8

Kratom poison control calls up more than 50-fold from 2011 to 2017 - https://t.co/YUHVYjGRJY https://t.co/U5qCyhDDew

RT @NBCNewsHealth: FDA tightens regulation of over-the-counter sunscreen products https://t.co/NjtSVfQ9jW

RT @FDASpox: In our latest #FDAVoices we talk about the PanPROE study, how Kaiser and FDA investigators hope to learn more about… https://t.co/nYjsvo6WP0

RT @FDAMedia: Statement from FDA Commissioner @SGottliebFDA, on efforts to spur development of innovative devices, including new… https://t.co/G8tLtoOgKk

RT @SecAzar: Watch live as I join my @HHSGov colleagues to reflect on what we accomplished together over the last year and where we are hea… QT @HHSGov: LIVE: @SecAzar delivers his 2019 State of the Department address. https://t.co/yRyTcswbIB)

#FDA today issued 74 product-specific guidances to support industry in identifying appropriate science-based methodologies and evidence for developing generic drugs. This is one way we are working to improve competition, promote access to medicines. https://t.co/UB33qoiOYL

RT @CDCDirector: New CDC-authored report shows flu vaccine prevented 109,000 flu hospitalizations and 8,000 flu deaths during the 20… https://t.co/GZYC0nc5Hh

While the numbers of inspections have varied by country over the past few years, total enforcement actions have increased. This is clear evidence that #FDA's risk-based surveillance model is working and our limited inspectional resources are targeted at the higher risk facilities https://t.co/13DhAB2APa

Over the past 4 years, FDA has a steady increase in foreign generic inspections. This coupled with risk-based manufacturing site selection has led to an increase in CGMP warning letters. We’ve issued nearly 5 times as many WLs to human drug manufacturers in FY18 as we did in FY15 https://t.co/o29Q8OZ1TY

RT @DrNancyM_CDC: What can we do to protect our youngest from #flu? Pediatrician, mom, and CDC #FluFighter @SeattleMamaDoc will take over… QT @CDCFlu: What can we do to protect our youngest from #flu? Pediatrician, mom, and CDC #FluFighter @SeattleMamaDoc will take… https://t.co/G0YlweFhW9)

RT @FDA_Drug_Info: Statement from FDA Commissioner @SGottliebFDA, and Director of FDA’s Center for Drug Evaluation and Research Janet… https://t.co/laZ2baLBcK

RT @SGottliebFDA: Use of TIRF medicines has declined sharply; about 3,500 patients currently use them. Our REMS is meant to mitigate… https://t.co/FRqZRwiIz3

As part of our push to increase generic competition, FDA published 74 product-specific guidances. Four of the new draft guidances and 45 of the revised guidances are for complex drugs, including 16 products for which there’s currently no approved generics. https://t.co/3SGwD1aq05

FDA is requiring manufacturers of opioids to conduct long term studies to evaluate whether the drugs maintain their effectiveness with chronic use. This is a critical question. Depending on what we learn it could lead to regulatory action to limit such use https://t.co/p1db7pWtuH

RT @FrankYiannasFDA: In the near future, you’ll also be able to scan a food item and trace it back to origin. Some companies are already… https://t.co/873WmrV3R2

RT @FrankYiannasFDA: Americans expect their food to be safe, whether its domestic or imported. Our new strategy is designed to leverage… https://t.co/4tjb2aRwBE

RT @FDAOncology: Check out this opportunity to work with us at #FDAOncology, @theNCI and @AACR on cancer research-related policy issues. Ap… QT @AACR: The deadline for the AACR Science Policy Fellowship application is midnight tonight. Don’t miss your chance to appl… https://t.co/KngsEe40K4)

FDA isn’t asking for applications to approve flavors in cigars. We’re issuing guidance to end enforcement discretion and then regulation to ban flavors in all cigars. There’s no place for flavors in cigars. This was made clear in our Nov 2018 announcement https://t.co/5FiuE4dyZd

RT @FDAOMH: FDA Office of Minority Health in collaboration with @SOPHEtweets is calling for abstracts for the Health Promotion… https://t.co/axFgWCGSxu

RT @FDAanimalhealth: Interested in helping FDA investigate the potential link between diet & � heart disease? Learn what you can do by v… https://t.co/SACVYQKyW8

Kratom poison control calls up more than 50-fold from 2011 to 2017 - https://t.co/YUHVYjGRJY https://t.co/U5qCyhDDew

RT @NBCNewsHealth: FDA tightens regulation of over-the-counter sunscreen products https://t.co/NjtSVfQ9jW

RT @FDASpox: In our latest #FDAVoices we talk about the PanPROE study, how Kaiser and FDA investigators hope to learn more about… https://t.co/nYjsvo6WP0

RT @FDAMedia: Statement from FDA Commissioner @SGottliebFDA, on efforts to spur development of innovative devices, including new… https://t.co/G8tLtoOgKk

RT @SecAzar: Watch live as I join my @HHSGov colleagues to reflect on what we accomplished together over the last year and where we are hea… QT @HHSGov: LIVE: @SecAzar delivers his 2019 State of the Department address. https://t.co/yRyTcswbIB)

#FDA today issued 74 product-specific guidances to support industry in identifying appropriate science-based methodologies and evidence for developing generic drugs. This is one way we are working to improve competition, promote access to medicines. https://t.co/UB33qoiOYL

RT @CDCDirector: New CDC-authored report shows flu vaccine prevented 109,000 flu hospitalizations and 8,000 flu deaths during the 20… https://t.co/GZYC0nc5Hh

While the numbers of inspections have varied by country over the past few years, total enforcement actions have increased. This is clear evidence that #FDA's risk-based surveillance model is working and our limited inspectional resources are targeted at the higher risk facilities https://t.co/13DhAB2APa

Over the past 4 years, FDA has a steady increase in foreign generic inspections. This coupled with risk-based manufacturing site selection has led to an increase in CGMP warning letters. We’ve issued nearly 5 times as many WLs to human drug manufacturers in FY18 as we did in FY15 https://t.co/o29Q8OZ1TY

RT @DrNancyM_CDC: What can we do to protect our youngest from #flu? Pediatrician, mom, and CDC #FluFighter @SeattleMamaDoc will take over… QT @CDCFlu: What can we do to protect our youngest from #flu? Pediatrician, mom, and CDC #FluFighter @SeattleMamaDoc will take… https://t.co/G0YlweFhW9)

RT @FDA_Drug_Info: Statement from FDA Commissioner @SGottliebFDA, and Director of FDA’s Center for Drug Evaluation and Research Janet… https://t.co/laZ2baLBcK

RT @SGottliebFDA: Use of TIRF medicines has declined sharply; about 3,500 patients currently use them. Our REMS is meant to mitigate… https://t.co/FRqZRwiIz3

As part of our push to increase generic competition, FDA published 74 product-specific guidances. Four of the new draft guidances and 45 of the revised guidances are for complex drugs, including 16 products for which there’s currently no approved generics. https://t.co/3SGwD1aq05

FDA is requiring manufacturers of opioids to conduct long term studies to evaluate whether the drugs maintain their effectiveness with chronic use. This is a critical question. Depending on what we learn it could lead to regulatory action to limit such use https://t.co/p1db7pWtuH

RT @FrankYiannasFDA: In the near future, you’ll also be able to scan a food item and trace it back to origin. Some companies are already… https://t.co/873WmrV3R2

RT @FrankYiannasFDA: Americans expect their food to be safe, whether its domestic or imported. Our new strategy is designed to leverage… https://t.co/4tjb2aRwBE